Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 86-5300 Flexible vs Cyclic Regimen for Dysmenorrhea
NCT01892904Phase 3Completed
- Sponsor
- Bayer
- Start
- Jul 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in dysmenorrhea, sponsored by Bayer. Started Jul 2013; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT01892904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01892904.